Furthermore, it has been indicated that administration of recombinant IL‐25 increases the viability, invasion, and migration of tumor cells, while blockade of IL‐25 with neutralizing antibodies leads to the apoptosis of tumor cells.41 The gene discussed is IL25; the disease is neoplasm.